Lithium Carbonate Tablet, Extended Release
Product Images NDC 70518-3681

2 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 70518-3681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Lithium Carbonate 300mg 70518 3681 00)

Mm1 (Lithium Carbonate 300mg 70518 3681 00)
Lithium Carbonate Tablet 300 mg extended-release oral tablets label. The package contains 30 tablets. Labeler is RemedyRepack Inc., Indiana, PA. The label includes storage instructions to protect from moisture and keep out of reach of children, with a note to see the insert for usual dosage. The manufacturer's information and NDC number 70518-3681-00 are also shown.*
FDA Label Image

Mm2 (Lithium Carbonate 300mg 70518 3681 01)

Mm2 (Lithium Carbonate 300mg 70518 3681 01)
Lithium Carbonate Tablet extended-release 300 mg, oral dosage form. The label shows a quantity of 30 round brown tablets. The product is repackaged by RemedyRepack Inc., with storage instructions to protect from moisture and keep at specific temperatures. The label includes the NDC number 70518-3681-01 and states RX only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.